http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018142106-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f366f3eb3a9328a75f8a72323d9f9a4b
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-31591
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-3232
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-2053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-2046
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-3234
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-3205
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-3158
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M5-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M5-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M5-315
filingDate 2018-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb0f34330672fb800c6dac440693968e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_519c3d995a80e320a8a2156e860a5c57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_39ee7c4e0bac94eafcf7de79b5e49c2c
publicationDate 2018-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2018142106-A1
titleOfInvention A medicament delivery device
abstract A medicament delivery device comprises a housing and a syringe axially movable in the housing and the syringe having a barrel. The device further comprises a stopper axially movable in the barrel and which separates a first chamber and second chamber from one another. The stopper is axially movable in the barrel in response to a vapour pressure being received in the second chamber. The device also includes a biasing mechanism to axially move the syringe in the housing between a first syringe position and a second syringe position in response to a first reduction in the vapour pressure in the second chamber. In the first syringe position venting of the propellant from the second chamber through a first fluid pathway is permitted to enable the first reduction in the vapour pressure in the second chamber while venting of the propellant from the second chamber through a second fluid pathway is substantially prevented. In the second syringe position venting of the propellant from the second chamber through the second fluid pathway is permitted to enable a second reduction in the vapour pressure in the second chamber.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022055759-A1
priorityDate 2017-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6045534-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419531920
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2776731

Total number of triples: 26.